Therapeutic effect of argatroban on rheumatoid vasculitis with antiphosphatidylserine-prothrombin complex antibody.
Kawakami
Tamihiro
T
Yamazaki
Masahide
M
Kawasaki
Kanade
K
Mizoguchi
Masako
M
Soma
Yoshinao
Y
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001172:Arthritis, Rheumatoid / Q000150:complications; D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D010718:Phosphatidylserines / Q000276:immunology; D010875:Pipecolic Acids / Q000627:therapeutic use*; D011516:Prothrombin / Q000276:immunology; D012867:Skin / Q000473:pathology; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*; D014657:Vasculitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000925:Anticoagulants; D001323:Autoantibodies; D010718:Phosphatidylserines; D010875:Pipecolic Acids; D013449:Sulfonamides; D011516:Prothrombin; D001120:Arginine; D013917:Thrombin; C031942:argatroban